Corporate Report

Overview

The report covers the fiscal year ended September 30, 2018, when consolidated net sales reached 37,909 million yen and operating profit reached 4,391 million yen. It presents the FujiPharma 2030 vision, including leadership in women's healthcare in Japan and Asia and an overseas sales ratio of 30% by 2030. Its Sustainability section highlights women's health, companywide environmental consideration and personnel development through the virtue evaluation scheme.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2018
Period: 1 October 2017 – 30 September 2018
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services